VASC Financial Facts

Total product costs and operating expenses: 26.72M
Total revenue: 31.93M
See Full Income Statement

Cash and cash equivalents: 41.65M
Current portion of deferred tax assets: 6M
See Full Balance Sheet

Vascular Solutions (VASC) Earnings

  |   Expand Research on VASC
Next EPS Date 4/21/15 EPS Growth Rate +12.5%
Average EPS % Beat Rate +7.4% Revenue Growth Rate +11.6%
Average % Move 1-Wk after EPS +3.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/21/15 Q115 N/A$0.18 N/A N/A$33.38M N/A N/A N/A
2/3/15 Q414 $0.23$0.18 +$0.05$33.6M$32.82M N/A Details
10/21/14 Q314 $0.15$0.20 -$0.05$31.9M$31.1M = Details
7/22/14 Q214 $0.20$0.18 +$0.02$30.7M$30.43M Details
4/22/14 Q114 $0.16N/A N/A $29.9M$26.1M Details
2/4/14 Q413 $0.22$0.19 +$0.03$29.1M$28.61M Details
10/22/13 Q313 $0.19$0.07 +$0.12$28M$27.1M Details
7/23/13 Q213 $0.17$0.17 $0.00$27.4M$27M Details